Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$173M |
| 2 |
Amcor
AMCR
|
+$138M |
| 3 |
Microsoft
MSFT
|
+$99.3M |
| 4 |
Amazon
AMZN
|
+$97.5M |
| 5 |
Intel
INTC
|
+$96.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$126M |
| 2 |
Alexandria Real Estate Equities
ARE
|
+$123M |
| 3 |
CHL
China Mobile Limited
CHL
|
+$58.6M |
| 4 |
IDTI
Integrated Device Technology I
IDTI
|
+$45.7M |
| 5 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$44.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.86% |
| 2 | Financials | 14.49% |
| 3 | Healthcare | 12.78% |
| 4 | Industrials | 10.5% |
| 5 | Consumer Discretionary | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Vanda Pharmaceuticals
VNDA
$304M
| $6.41M | ﹤0.01% |
454,759
+18,447
| +4% | +$294K |
|
1852
Travere Therapeutics
TVTX
$5.79B
| $6.4M | ﹤0.01% |
318,764
+26,358
| +9% | +$520K |
|
1853
St. Joe Company
JOE
$3.89B
| $6.4M | ﹤0.01% |
370,171
+36,900
| +11% | +$619K |
|
1854
Stoneridge
SRI
$201M
| $6.37M | ﹤0.01% |
201,765
+27,537
| +16% | +$815K |
|
1855
Bank of N.T. Butterfield & Son
NTB
$2.51B
| $6.36M | ﹤0.01% |
187,199
+7,469
| +4% | +$276K |
|
1856
Smith & Wesson
SWBI
$643M
| $6.34M | ﹤0.01% |
915,058
+13,383
| +1% | +$94.8K |
|
1857
Veracyte
VCYT
$3.42B
| $6.32M | ﹤0.01% |
221,763
+55,652
| +34% | +$1.39M |
|
|
MNK
1858
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $6.32M | ﹤0.01% |
688,612
+71,577
| +12% | +$1.03M |
|
1859
AtriCure
ATRC
$2.21B
| $6.31M | ﹤0.01% |
211,390
+4,506
| +2% | +$132K |
|
1860
First Bancorp
FBNC
$2.74B
| $6.31M | ﹤0.01% |
173,181
+3,812
| +2% | +$139K |
|
1861
Universal Electronics
UEIC
$66.6M
| $6.29M | ﹤0.01% |
153,256
-8,395
| -5% | -$336K |
|
1862
Pitney Bowes
PBI
$2.28B
| $6.28M | ﹤0.01% |
1,468,012
+49,963
| +4% | +$268K |
|
1863
Tompkins Financial
TMP
$1.45B
| $6.28M | ﹤0.01% |
76,960
+1,712
| +2% | +$136K |
|
1864
DXP Enterprises
DXPE
$3B
| $6.25M | ﹤0.01% |
164,996
+1,966
| +1% | +$75.5K |
|
|
LTHM
1865
DELISTED
Livent Corporation
LTHM
| $6.25M | ﹤0.01% |
902,884
+12,347
| +1% | +$111K |
|
|
MODV
1866
DELISTED
ModivCare
MODV
| $6.25M | ﹤0.01% |
108,919
+4,735
| +5% | +$307K |
|
|
EGRX
1867
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $6.23M | ﹤0.01% |
111,946
+14,111
| +14% | +$736K |
|
1868
CTS Corp
CTS
$1.79B
| $6.23M | ﹤0.01% |
225,939
+22,276
| +11% | +$641K |
|
|
APLS
1869
DELISTED
Apellis Pharmaceuticals
APLS
| $6.22M | ﹤0.01% |
245,472
+34,064
| +16% | +$693K |
|
1870
Magnolia Oil & Gas
MGY
$6.13B
| $6.22M | ﹤0.01% |
537,219
+212,298
| +65% | +$2.6M |
|
1871
GameStop
GME
$8.33B
| $6.2M | ﹤0.01% |
4,529,900
+355,416
| +9% | +$695K |
|
1872
Artivion
AORT
$1.39B
| $6.19M | ﹤0.01% |
206,940
+7,823
| +4% | +$232K |
|
|
RDUS
1873
DELISTED
Radius Health, Inc.
RDUS
| $6.15M | ﹤0.01% |
252,470
+16,474
| +7% | +$360K |
|
1874
3D Systems Corp
DDD
$601M
| $6.14M | ﹤0.01% |
674,957
+35,831
| +6% | +$339K |
|
1875
AMC Entertainment Holdings
AMC
$2.35B
| $6.12M | ﹤0.01% |
65,541
+3,908
| +6% | +$521K |
|
Similar funds
Charles Schwab's Q2 2019 Portfolio in Review
As of Q2 2019, Charles Schwab held 3,341 positions worth $164B, up 5.3% from $156B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Charles Schwab's Q2 2019 filing shows 147 new, 2,302 increased, 628 reduced and 129 closed positions. Its largest new stake was Dow Inc: 3,280,629 shares worth $162M. The largest sale was DuPont de Nemours, an estimated $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2019 buy was Dow Inc: 3,280,629 shares worth $162M.
- Charles Schwab added most to Microsoft in Q2 2019, an estimated $99.3M increase.
- Charles Schwab's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $126M.
- Charles Schwab fully exited China Mobile Limited in Q2 2019, selling an estimated $58.6M.
- Charles Schwab's ten largest holdings make up 15% of its $164B portfolio in Q2 2019.
- Charles Schwab opened 147 new positions and closed 129 in Q2 2019.
- Charles Schwab's portfolio value rose 5.3% quarter-over-quarter to $164B.
Based on Charles Schwab's 13F filing for Q2 2019, filed 9 Aug 2019.